baytril 25 mg/ml inj. sol. s.c. vial
bayer animal health gmbh - enrofloxacin 25 mg/ml - solution for injection - 25 mg/ml - enrofloxacin 25 mg/ml - enrofloxacin - dog; cat; pig; rabbit; other species or species not known; ornamental bird
baytril flavour 25 mg/ml or. susp.
bayer animal health gmbh - enrofloxacin 25 mg/ml - oral suspension - 25 mg/ml - enrofloxacin 25 mg/ml - enrofloxacin - cat
doraflox 25 mg/ml or. sol.
vetpharma animal health s.l. - enrofloxacin 25 mg/ml - oral solution - 25 mg/ml - enrofloxacin 25 mg/ml - enrofloxacin - cattle
enrobactin 25 mg/ml or. sol. (conc.)
dechra regulatory b.v. - enrofloxacin 25 mg/ml - concentrate for oral solution - 25 mg/ml - enrofloxacin 25 mg/ml - enrofloxacin - rabbit; other species or species not known; ornamental bird
orniflox 25 mg/ml or. sol. (conc.)
avimedical b.v. - enrofloxacin 25 mg/ml - concentrate for oral solution - 25 mg/ml - enrofloxacin 25 mg/ml - enrofloxacin - rabbit; ornamental bird; other species or species not known
enrofloxacin flavored- enrofloxacin tablet, chewable
putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
unisol 5 mg/ml oral solution for piglets
vetpharma animal health, s.l. - enrofloxacin - oral solution - 5 milligram(s)/millilitre - enrofloxacin - pigs - antibacterial
unisol 25 mg/ml oral solution for calves
vetpharma animal health, s.l. - enrofloxacin - oral solution - 25 milligram(s)/millilitre - enrofloxacin - cattle - antibacterial
enrocare 25 mg/ml oral solution for pet rabbits, rodents, ornamental birds and reptiles
ecuphar nv - enrofloxacin - oral solution - 25 milligram(s)/millilitre - enrofloxacin
enrofloxacin flavored- enrofloxacin tablet
felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.